Protein Kinases and Protein Phosphorylation
Protein Kinases and Protein Phosphorylation
批准号:
8597864
负责人:
Reuben Shaw
金额:
$0.4万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-10 至 2014-07-09
关键词:
AcademiaAffectAnniversaryAntineoplastic AgentsAreaAutophagocytosisBiochemicalBiological ProcessCancer BiologyCell physiologyCellular biologyChairpersonClinicClinicalClinical TrialsCollaborationsCommunicationCommunication ResearchDataDevelopmentDiagnosisDisciplineDiseaseDoctor of PhilosophyEnsureEnzymesEventFacultyFeedbackFertilizationFosteringFutureGeneticGoalsGrowth and Development functionHome environmentHumanHuman GenomeIndustryInstitutionInternationalKnowledgeLaboratoriesMalignant NeoplasmsMediatingMetabolismMinorityMolecularMutationNew YorkPathway interactionsPharmacologic SubstancePhosphorylationPhosphotransferasesPlayPreventionProtein KinaseProtein Kinase Protein PhosphorylationRas/RafRecruitment ActivityRegulationReportingResearchResearch PersonnelResistanceRoleRunningScientistSignal PathwaySignal TransductionSourceStagingStructureStudentsSystemTechnologyTherapeuticTherapeutic InterventionTimeTranslational ResearchWomanWorkabstractinganticancer researchbasecell growthdevelopmental diseasefallshuman FRAP1 proteinhuman diseaseimprovedinhibitor/antagonistinsightinterestkinase inhibitorlecturesmeetingsmembernew technologynew therapeutic targetnext generationnovelnovel strategiesnovel therapeuticspostersprofessorpublic health relevanceresistance mechanismsymposiumtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of the signal transduction field is to identify and characterize the biochemical and molecular basis of communication from one molecule to another as part of a signaling pathway. Over the last 30 years, this knowledge has provided a vastly improved understanding of how kinases and phosphorylation events control all known cellular processes associated with normal growth and development. Unfortunately, these pathways are also deregulated through an assortment of mechanisms, and when this occurs a variety of human developmental disorders and diseases arise. There are over 500 protein kinases in the human genome with the potential to regulate protein phosphorylation, but relatively few are well characterized. Of those that are, many are now known to possess important functions in normal development and disease. Because of the central role these enzymes play in a variety of biological processes and in many human diseases, and because protein kinases are potential targets for therapeutic intervention, a tremendous effort has been made at determining the molecular basis for information transmission and the biological processes affected. The characterization of new kinases and their functions will likely reveal even more novel therapeutic targets. The study of molecular cancer research has often been intertwined with advances in the study of kinases and phosphorylation, as it is now known that alterations in kinases are amongst the most common mutations found across nearly all known forms of human cancer. As a result, kinase inhibitors have emerged as the most prevalent form of anti-cancer agents in the past 50 years, with hundreds of new kinase inhibitors entering clinical trials every year for the past few years. These are truly exciting times in the protein kinase and protein phosphorylation arena. Thus, it is critical that the exchange of information and ideas between the leading scientists in the field occur in order for this scientific discovery o proceed. Since its inception in 1983, the FASEB summer research conference on "Protein Kinases and Protein Phosphorylation" (held biennially) has consistently been one of the preeminent meetings in the field of signal transduction, providing a premier venue for the communication of research findings from both academia and industry. The goal of the proposed conference is to continue this tradition of exciting and enthusiastic scientific exchange.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma
-
批准号:10629065
-
项目类别:
-
资助金额:$46.68万
-
财政年份:2023
-
负责人:Reuben Shaw
-
依托单位:
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
-
批准号:10667573
-
项目类别:
-
资助金额:$114.07万
-
财政年份:2017
-
负责人:Reuben Shaw
-
依托单位:
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
-
批准号:10448279
-
项目类别:
-
资助金额:$114.07万
-
财政年份:2017
-
负责人:Reuben Shaw
-
依托单位:
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
-
批准号:10222594
-
项目类别:
-
资助金额:$116.4万
-
财政年份:2017
-
负责人:Reuben Shaw
-
依托单位:
AMPK and AMPK-related kinases in lung cancer development and treatment
-
批准号:8605862
-
项目类别:
-
资助金额:$39.05万
-
财政年份:2013
-
负责人:Reuben Shaw
-
依托单位:
AMPK and AMPK-related kinases in lung cancer development and treatment
-
批准号:8785659
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2013
-
负责人:Reuben Shaw
-
依托单位:
AMPK and AMPK-related kinases in lung cancer development and treatment
-
批准号:8420203
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2013
-
负责人:Reuben Shaw
-
依托单位:
AMPK and AMPK-related kinases in lung cancer development and treatment
-
批准号:9186506
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2013
-
负责人:Reuben Shaw
-
依托单位:
AMPK and AMPK-related kinases in lung cancer development and treatment
-
批准号:8984294
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2013
-
负责人:Reuben Shaw
-
依托单位:
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in Liver
-
批准号:7353028
-
项目类别:
-
资助金额:$35.43万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
LKB1- AMPK pathway regulation of glucose metabolism and metformin action in liver
-
批准号:8373413
-
项目类别:
-
资助金额:$46.56万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in Liver
-
批准号:7653640
-
项目类别:
-
资助金额:$34.72万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
LKB1/AMPK signaling and Peutz-Jeghers syndrome
-
批准号:9120335
-
项目类别:
-
资助金额:$27.09万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
LKB1/AMPK signaling and Peutz-Jeghers syndrome
-
批准号:8448867
-
项目类别:
-
资助金额:$27.91万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in Liver
-
批准号:7883224
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
LKB1- AMPK pathway regulation of glucose metabolism and metformin action in liver
-
批准号:8683156
-
项目类别:
-
资助金额:$46.56万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
LKB1- AMPK pathway regulation of glucose metabolism and metformin action in liver
-
批准号:8874208
-
项目类别:
-
资助金额:$46.56万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
LKB1/AMPK signaling and Peutz-Jeghers syndrome
-
批准号:8915514
-
项目类别:
-
资助金额:$27.13万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
Role of LKB1 and AMPK in Metformin and TZD Control of Glucose Metabolism in Liver
-
批准号:8098166
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
LKB1/AMPK signaling and Peutz-Jeghers syndrome
-
批准号:8719040
-
项目类别:
-
资助金额:$26.37万
-
财政年份:2007
-
负责人:Reuben Shaw
-
依托单位:
海外基金